Mesenchymal stem cells (MSCs) are multipotent progenitor cells capable of developing into a variety of cell types, such as adipocytes, chondrocytes, osteocytes, and cardiomyocytes. Population aging and an increasing prevalence of chronic disease are driving interest in MSC-based therapies.
Over the past 150 years, the average human lifespan has doubled and continued increases in life-expectancy are expected.
In China, the country expects to have half a billion people over the age 60 by 2050. In Japan, the government expects to have 50% of the population over 65 within two decades. Similar demographics are affecting Europe and the United States, all of which are accelerating the market opportunities for cell-based therapeutics, such as MSCs. [Read more…]